Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CohortCOHTF 94 Days Sales Outstanding is 115.31 as of Apr. 2026, which is 98% above its 10-year median of 58.13. GuruFocus rates COHTF with a GF Score™ of 94/100 and a GF Value™ of $17.49. The stock has 6 warning signs investors should review. Among 350 Aerospace & Defense companies, Cohort ranks worse than 57.71% on this metric.
Cohort's average Accounts Receivable for the
six
months ended in Apr. 2026 was $150.3 Mil. Cohort's Revenue for the
six
months ended in Apr. 2026 was $237.9 Mil.
Hence, Cohort's Days Sales Outstanding for the
six
months ended in Apr. 2026 was 115.31.
The historical rank and industry rank for Cohort's Days Sales Outstanding or its related term are showing as below:
COHTF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.27 Med: 58.13 Max: 75.25
Current: 75.25
During the past 13 years, Cohort's highest Days Sales Outstanding was 75.25. The lowest was 47.27. And the median was 58.13.
COHTF's Days Sales Outstanding is ranked worse than 57.71% of 350
companies
in the Aerospace & Defense industry
Industry Median: 64.28
vs COHTF: 75.25
Cohort's Days Sales Outstanding
increased
from Apr. 2025 (92.80) to Apr. 2026 (115.31).
Cohort (OTCPK:COHTF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Cohort Days Sales Outstanding Related Terms
Cohort Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Cohort's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COHTF vs SPCX, GE, RTX: Days Sales Outstanding Comparison
For the Aerospace & Defense subindustry, Cohort's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cohort Days Sales Outstanding vs Aerospace & Defense Industry
For the Aerospace & Defense industry and Industrials sector, Cohort's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cohort's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 115.31 mean?
Cohort (COHTF) has a Days Sales Outstanding of 115.31 as of Apr. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cohort and its competitors. This is 98% above median its historical median of 58.13. Over the past decade, Cohort's Days Sales Outstanding has ranged from 47.27 to 75.25. According to the industry distribution chart, Cohort ranks #202 out of 350 companies in the Aerospace & Defense industry, placing it in the top 57.7%.
Is Cohort's Days Sales Outstanding too high?
Cohort's current Days Sales Outstanding of 115.31 is 98% above median its 10-year median of 58.13. Over the past 10 years, this metric has ranged from a low of 47.27 to a high of 75.25. The Aerospace & Defense industry median Days Sales Outstanding is 64.28. Cohort's value of 115.31 is 79.4% above this industry median. Based on the distribution chart, Cohort ranks #202 out of 350 companies in the Aerospace & Defense industry, which is below the industry midpoint. Overall, Cohort has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Cohort's Days Sales Outstanding compare to SPCX and GE?
According to the Aerospace & Defense industry distribution chart, Cohort ranks #202 out of 350 companies for Days Sales Outstanding. This places Cohort in the lower half of its industry. The industry median Days Sales Outstanding is 64.28. Cohort's value of 115.31 is 79.4% above this benchmark. Historically, Cohort's own Days Sales Outstanding has ranged from 47.27 to 75.25 over the past decade. While the company's 10-year median is 58.13 vs. the industry median of 64.28, Cohort has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for an Aerospace & Defense company?
The median Days Sales Outstanding among Aerospace & Defense companies is 64.28, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cohort's current Days Sales Outstanding of 115.31 is 79.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cohort and its competitors. For the Aerospace & Defense industry, the median Days Sales Outstanding is 64.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cohort's current Days Sales Outstanding is 115.31, which is 98% above median its own 10-year median of 58.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cohort stock overvalued right now?
Cohort (COHTF) has a current Days Sales Outstanding of 115.31. The stock's GF Value™ is $17.49, compared to a current price of $16.47 — trading 5.9% below its estimated fair value. The current Days Sales Outstanding is 115.31, which is 98% above median its 10-year median of 58.13 and 79.4% above the Aerospace & Defense industry median of 64.28. Cohort's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Cohort (COHTF), the current Days Sales Outstanding is 115.31 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cohort (COHTF) Overvalued in 2026?
Based on GuruFocus' analysis, Cohort stock appears to be undervalued.
The current stock price of $16.47 is trading 5.9% below its estimated GF Value™ of $17.49.
Key valuation signals for COHTF:
Days Sales Outstanding: 115.31 (98% above median its 10-year median of 58.13)
GF Value™: $17.49 vs. price of $16.47 (5.9% below fair value)
Industry Position: 79.4% above the Aerospace & Defense median (#202 of 350)
No single metric tells the full story. See the COHTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cohort PLC is the parent company of seven businesses that provide services and products for customers in the defence, security, and related sectors in the United Kingdom and international markets. Its businesses include Chess, EID, ELAC Sonar, EM Solutions, MASS, MCL and SEA. The company has operations in UK, Portugal, Australia and Canada.
94GF Score
Get the complete analysis for COHTF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COHTF has been successfully added to your 
